Menu Menu


COVID-19 Research Pipeline


Registered/ Published






As at 14 October 2021
FILTERED BY > Dexamethasone Clear filter

EXPLAINER: What happens if I test positive to COVID-19?

19 July, 2021
With the recent COVID-19 outbreak in NSW and Victoria, it’s timely to revisit what happens if you test positive with COVID-19.  With so much media commentary and coverage from all over the globe it can be hard for clinicians and consumers to sort fact from fiction. The National COVID-19 Clinical Evidence Taskforce is a coalition of 32 peak health organisations...

Saving lives safely: Taskforce issues guidance on CPR during the pandemic

22 October, 2020
Healthcare workers and trained first aid responders are being urged not to delay commencing cardiopulmonary resuscitation (CPR) because of the COVID-19 pandemic. The National COVID-19 Clinical Evidence Taskforce,...
Media Release

COVERAGE: A/Prof Julian Elliott on Trump treatment

7 October, 2020
Our Executive Director, A/Prof Julian Elliott spoke with Liam Mannix from The Age and Sydney Morning Herald about President Trump's treatment for COVID-19.      

Weekly Communique # 23

17 September, 2020
WEEK IN REVIEW New recommendations on VTE prophylaxis for pregnant and postpartum women The Pregnancy and Perinatal Care Panel together with the Expert Advisory Group have developed four new consensus...

Taskforce makes recommendation for use of dexamethasone for patients receiving oxygen

3 July, 2020
The National COVID-19 Clinical Evidence Taskforce today gave a conditional recommendation for use of dexamethasone for the treatment of people with COVID-19 who are receiving oxygen or mechanical ventilation. The...
Media Release

Statement from the National COVID-19 Clinical Evidence Taskforce on media release of results of dexamethasone arm of the UK RECOVERY Trial

17 June, 2020
The National COVID-19 Clinical Evidence Taskforce (the Taskforce) has noted the media release of preliminary results from the dexamethasone arm of the RECOVERY (Randomised Evaluation of COVid-19 thERapY)...
Media Release